Product Information

ZITUVIMET 50-1,000 MG TABLET is a brand product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $5.0293 per EA under NDC 70710178706. Its NADAC has been published 70 times since Apr 23, 2025.

FDA first approved this application on Nov 3, 2023.

ZITUVIMET 50-1,000 MG TABLET

Sitagliptin and Metformin Hydrochloride
$5.0293per EA

Strength

1000; 50 mg/1; mg/1

NDC

70710178706

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA216743

FDA Approved

11/3/2023

On Market Since

3/14/2024

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for ZITUVIMET 50-1,000 MG TABLET has been published 70 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$5.0293 per EA
All-time high$5.0496 (May 14, 2025)
All-time low$5.0274 (Jul 22, 2026)
52-week high$5.0407
52-week low$5.0274
Median price$5.0375
Average price$5.0374
Largest weekly change+0.2% (Jul 23, 2025)
Weeks tracked70
Tracking sinceApr 23, 2025

Price History

1W

+0.0%

1M

+0.0%

3M

-0.0%

6M

-0.2%

1Y

-0.2%

3Y

N/A

5Y

N/A

All

-0.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sitagliptin and Metformin Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ZITUVIMET 50-1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZITUVIMET 50-1,000 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $5.0293 per EA (NDC 70710178706), effective Aug 19, 2026.

How has the price of ZITUVIMET 50-1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZITUVIMET 50-1,000 MG TABLET has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since Apr 23, 2025.

What are the highest and lowest recorded NADAC prices for ZITUVIMET 50-1,000 MG TABLET?

Since Apr 23, 2025, the NADAC for ZITUVIMET 50-1,000 MG TABLET has ranged from a low of $5.0274 (Jul 22, 2026) to a high of $5.0496 (May 14, 2025), with a median of $5.0375 per EA.

Are there cheaper alternatives to ZITUVIMET 50-1,000 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ZITUVIMET 50-1,000 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ZITUVIMET 50-1,000 MG TABLET?

ZITUVIMET 50-1,000 MG TABLET (NDC 70710178706) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a brand product.